Hibiscus Sabdariffa como candidato terapéutico para COVID-19
Barra lateral del artículo
Publicado:
oct. 2, 2020
Contenido principal del artículo
Descargas
Los datos de descargas todavía no están disponibles.
Detalles del artículo
Cómo citar
Parga-Lozano, C. (2020). Hibiscus Sabdariffa como candidato terapéutico para COVID-19. Duazary, 17(4), 1–3. https://doi.org/10.21676/2389783X.3597
Sección
Editorial
No se permite un uso comercial de la obra original ni de las posibles obras derivadas, la distribución de las cuales se debe hacer con una licencia igual a la que regula la obra original.
Citas
1. Ksiazek TG, Erdman D, Goldsmith CS, Sherif C, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953–1966. Doi: https://www.nejm.org/doi/full/10.1056/NEJMoa030781
2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier R. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. Doi: https://www.nejm.org/doi/full/10.1056/NEJMoa1211721
3. Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93–116. Doi: https://doi.org/10.1016/bs.aivir.2019.08.002.
4. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 Mar 12. Doi: https://doi.org/10.1007/s11684-020-0754-0
5. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J AllergyI mmunol2020;38:1-9 Doi: 10.12932/AP-200220-0772
6. Thevarajan I, Nguyen T, Koutsakos M, Druce J, Caly L, van de Sandt C, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med (2020). Doi: https://doi.org/10.1038/s41591-020-0819-2
7. Li G,FanY, LaiY, HanT, Li Z, ZhouP, Pan P, WangW, HuD, LiuX, ZhangQ, Wu J. Coronavirus infections and immune responses. Journal of Medical Virology. 25 January 2020 Doi: https://doi.org/10.1002/jmv.25685
8. De Pascale G, Cutuli SL, Pennisi MA, Antonelli M. The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm. 2013:625803. Doi: https://doi.org/10.1155/2013/625803.
9. Fitzgerald M, Heinrich M, Booker A. Medicinal Plant Analysis: A Historical and Regional Discussion of Emergent Complex Techniques. Front Pharmacol. 2020 Jan 9;10:1480. Doi: https://doi.org/10.3389/fphar.2019.01480.
10. Zhang H, Penninger JM, Yimin L, Zhong N, Slutsky A. Angiotensin converting enzyme 2 (ACE2) as a SARS CoV 2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. Doi: https://doi.org/10.1007/s00134-020-05985-9.
11. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 2020;30:269–271. Doi: https://doi.org/10.1038/s41422-020-0282-0.
12. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020 Mar 9. Doi: https://doi.org/10.1093/cid/ciaa237.
13. Sara S. Al Disi, M. Akhtar Anwarand Ali H. Eid. Anti-hypertensive Herbs and their Mechanisms of Action: Part I. Front. Pharmacol., 19 January 2016 Doi: https://doi.org/10.3389/fphar.2015.00323.
14. Herrera-Arellano A, Miranda-Sanchez J, Avila-Castro P, Herrera-Alvarez S, Jimenez-Ferrer J, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscuss abdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007. 73, 6–12. DOI: 10.1055/s-2006-957065. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2006-957065.
15. Barral M. Hibiscuss abdariffa: propiedades terapéuticas. Trabajo fin de grado. Facultad de Farmacia Universidad Complutense de Madrid. 2018. http://147.96.70.122/Web/TFG/TFG/Memoria/MARIA%20LUISA%20BARRAL%20GONZALEZ.pdf.
2. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus A, Fouchier R. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. Doi: https://www.nejm.org/doi/full/10.1056/NEJMoa1211721
3. Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93–116. Doi: https://doi.org/10.1016/bs.aivir.2019.08.002.
4. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 Mar 12. Doi: https://doi.org/10.1007/s11684-020-0754-0
5. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J AllergyI mmunol2020;38:1-9 Doi: 10.12932/AP-200220-0772
6. Thevarajan I, Nguyen T, Koutsakos M, Druce J, Caly L, van de Sandt C, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med (2020). Doi: https://doi.org/10.1038/s41591-020-0819-2
7. Li G,FanY, LaiY, HanT, Li Z, ZhouP, Pan P, WangW, HuD, LiuX, ZhangQ, Wu J. Coronavirus infections and immune responses. Journal of Medical Virology. 25 January 2020 Doi: https://doi.org/10.1002/jmv.25685
8. De Pascale G, Cutuli SL, Pennisi MA, Antonelli M. The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm. 2013:625803. Doi: https://doi.org/10.1155/2013/625803.
9. Fitzgerald M, Heinrich M, Booker A. Medicinal Plant Analysis: A Historical and Regional Discussion of Emergent Complex Techniques. Front Pharmacol. 2020 Jan 9;10:1480. Doi: https://doi.org/10.3389/fphar.2019.01480.
10. Zhang H, Penninger JM, Yimin L, Zhong N, Slutsky A. Angiotensin converting enzyme 2 (ACE2) as a SARS CoV 2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. Doi: https://doi.org/10.1007/s00134-020-05985-9.
11. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research 2020;30:269–271. Doi: https://doi.org/10.1038/s41422-020-0282-0.
12. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020 Mar 9. Doi: https://doi.org/10.1093/cid/ciaa237.
13. Sara S. Al Disi, M. Akhtar Anwarand Ali H. Eid. Anti-hypertensive Herbs and their Mechanisms of Action: Part I. Front. Pharmacol., 19 January 2016 Doi: https://doi.org/10.3389/fphar.2015.00323.
14. Herrera-Arellano A, Miranda-Sanchez J, Avila-Castro P, Herrera-Alvarez S, Jimenez-Ferrer J, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscuss abdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007. 73, 6–12. DOI: 10.1055/s-2006-957065. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2006-957065.
15. Barral M. Hibiscuss abdariffa: propiedades terapéuticas. Trabajo fin de grado. Facultad de Farmacia Universidad Complutense de Madrid. 2018. http://147.96.70.122/Web/TFG/TFG/Memoria/MARIA%20LUISA%20BARRAL%20GONZALEZ.pdf.